PEB Pacific Edge's APAC operations advancing towards profit with cancer test growth Pacific Edge APAC business is advancing towards profitability on a direct-cost basis with a growing interest in its testing services. Colin Sandell-Hay 3 hours ago ASX News Healthcare Biotechnology
ENP Entropy reports 50% remission in Phase 2 psychedelic trial for binge eating disorder Entropy Neurodynamics says its Phase 2 trial of TRP-8803 delivered 50% remission in all treatment-resistant binge eating disorder patients. Seja Al Zaidi 7 days ago ASX News Healthcare Psychedelics
AFP AFT Pharmaceuticals reports ongoing sales growth and R&D progress AFT Pharmaceuticals has achieved sustained growth at the start of the 2027 FY and is on track to reach its $300 million revenue target. Colin Sandell-Hay 07 Jul 2026 09:36 (AEST) ASX News Healthcare Steel Drug Manufacturers - Specialty & Generic Basic Materials
SNT Syntara shows encouraging first signals it can impact the path to Parkinson's Syntara (ASX:SNT) has reported encouraging interim results from its Phase 2 study of SNT-4728, providing the first clinical evidence that the company’s novel anti-inflammatory therapy may be targeting a key biological process linked to the development of Parkinson’... Isaac McIntyre 06 Jul 2026 12:34 (AEST) ASX News Healthcare Drug Manufacturers - Specialty & Generic
SNT Syntara reports encouraging early Parkinson's trial results Syntara has reported statistically significant reductions in brain inflammation in an early-stage Parkinson's disease study. Seja Al Zaidi 06 Jul 2026 11:54 (AEST) ASX News Healthcare Drug Manufacturers - Specialty & Generic
OSL OncoSil Medical files for US FDA approval for specialist device OncoSil Medical has hit a key milestone in its plans to commercialise its unique OncoSil device for the treatment of dCCA. Colin Sandell-Hay 03 Jul 2026 15:27 (AEST) ASX News Healthcare Medical Devices
NOX Noxopharm welcomes award of childbirth MRFF grant for Sofra platform Noxopharm has welcomed the awarding of a $1 million medical research future fund grant for a project involving the company’s Sofra platform. Colin Sandell-Hay 02 Jul 2026 12:37 (AEST) ASX News Healthcare Steel Biotechnology Basic Materials
1AI Algorae secures NSW Health hospital supply agreement through AlgoraeRx Algorae Pharmaceuticals has secured a NSW Health standing offer arrangement through its AlgoraeRx division. Seja Al Zaidi 02 Jul 2026 11:49 (AEST) ASX News Healthcare Biotechnology
MEM Memphasys secures exclusive $430K Thailand distribution deal for Felix sperm system Memphasys (ASX:MEM) has signed a three-year Thailand distribution deal with IVF Envimed for its Felix sperm separation system. The exclusive contract guarantees A$430,500 over its three-year term, boosting the company’s South-East Asian revenue to A$1 million and driving total FY2... Isaac McIntyre 01 Jul 2026 10:21 (AEST) ASX News Healthcare Biotechnology
NEU Neuren Pharmaceuticals welcomes milestone approval for Daybu Neuren Pharmaceuticals has received positive news for the proposed marketing of the Daybu treatment of Rett syndrome. Colin Sandell-Hay 29 Jun 2026 09:53 (AEST) ASX News Healthcare Biotechnology
OSX Osteopore wraps up recruitment into 3D printing support for cleft lip patients Osteopore has completed recruitment of all five patients required for the clinical trial of paranasal augmentation with unilateral cleft lip. Colin Sandell-Hay 26 Jun 2026 12:50 (AEST) ASX News Healthcare
MEM Memphasys secures UK market entry, accelerating commercial rollout Memphasys has entered the U.K. fertility market with four IVF groups putting in commercial orders to trial its Felix system. Seja Al Zaidi 25 Jun 2026 11:52 (AEST) ASX News Healthcare Biotechnology
HYD Hydrix engaged to advance AI robotic stroke therapy platform Hydrix has been engaged by Quantanosis Ai to support development of a next-generation robotic stroke treatment platform. Colin Sandell-Hay 24 Jun 2026 15:36 (AEST) ASX News Healthcare Technology Scientific & Technical Instruments
